SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-20-000071
Filing Date
2020-03-23
Accepted
2020-03-23 16:33:50
Documents
8
Effectiveness Date
2020-03-23

Document Format Files

Seq Description Document Type Size
1 AMNEAL PHARMACEUTICALS, INC. - DEFA14A lamrx2020_defa14a.htm DEFA14A 14918
2 GRAPHIC check.jpg GRAPHIC 1317
3 GRAPHIC lamrx_proxy001.jpg GRAPHIC 197853
4 GRAPHIC lamrx_proxy002.jpg GRAPHIC 315724
5 GRAPHIC lamrx_proxy003.jpg GRAPHIC 76655
6 GRAPHIC lamrx_proxy004.jpg GRAPHIC 19745
7 GRAPHIC uncheck.jpg GRAPHIC 1182
8 GRAPHIC lamrxx1x1.jpg GRAPHIC 11705
  Complete submission text file 0001308179-20-000071.txt   876472
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38485 | Film No.: 20735273
SIC: 2834 Pharmaceutical Preparations